Genocea Biosciences Inc (GNCAQ)

[db7]

regarding 'strategic plans':

"
...
Fourth quarter 2021 financial results
...
Net loss: Net loss was $13.3 million...
....
Guidance
Genocea’s existing cash is sufficient to support our current operations into Q3 2022, however we have strategic plans to extend our operations into 2023.
...
"

So, assuming we're talking about these 'strategic plans' bringing us $25-$30million...

$25-$30million:
... could be (hoping!) a nice upfront payment on a partnership?
... would be ~25-30million share dilution if a raise at $1
... would be ~16.67-20million share dilution if a raise at $1.5
... would be ~12.5-15million share dilution if a raise at $2

won't be long now and we'll have some answers... g/l!